Cerevel Therapeutics Holdings News

About 67% of Cerevel Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Cerevel Therapeutics Holdings suggests that many traders are alarmed regarding Cerevel Therapeutics' prospects. The current market sentiment, together with Cerevel Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Cerevel Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at gurufocus.com         
Director N Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings Inc
Gurufocus Stories at Macroaxis
over six months ago at investing.com         
Cerevel Therapeutics director sells 2.12m in stock, buys 175k worth
Investing News at Macroaxis
over six months ago at simplywall.st         
Ceres Earnings May Just Be The Starting Point
Simply Wall St News at Macroaxis
over six months ago at finance.yahoo.com         
Got 3,000 2 Monster Growth Stocks to Buy Right Now Without Hesitation
Yahoo News
over six months ago at www.macroaxis.com         
Disposition of 50000 shares by Coles N Anthony of Cerevel Therapeutics at 42.3328 subject to Rule 16...
Macroaxis News
over six months ago at news.google.com         
Disposition of 22824 shares by Coles N Anthony of Cerevel Therapeutics at 3.5 subject to Rule 16b-3
Google News at Macroaxis
over six months ago at news.google.com         
Assenagon Asset Management S.A. Invests 12.72 Million in Cerevel Therapeutics Holdings, Inc. - Marke...
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Disposition of 10000 shares by Sanchez Ramiro of Cerevel Therapeutics at 3.5 subject to Rule 16b-3
Macroaxis News
over six months ago at finance.yahoo.com         
Investors file record number of climate resolutions for North American companies
Yahoo News
over six months ago at finance.yahoo.com         
AbbVie to buy immune drug developer Landos
Yahoo News
over six months ago at news.google.com         
Cerevel Therapeutics to Present at Upcoming Virtual Investor Conferences - The Globe and Mail
Google News at Macroaxis
over six months ago at simplywall.st         
Ceres earnings have declined over three years, contributing to shareholders 58 percent loss
Simply Wall St News at Macroaxis
over six months ago at news.google.com         
Technical Data - Stock Traders Daily
Google News at Macroaxis
over six months ago at cnbc.com         
Jefferies likes these dividend-growing stocks for 2024
cnbc News
over six months ago at news.google.com         
Hudson Bay Capital Management LP Invests 1.09 Million in Cerevel Therapeutics Holdings, Inc. - Marke...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Cerevel Therapeutics that are available to investors today. That information is available publicly through Cerevel media outlets and privately through word of mouth or via Cerevel internal channels. However, regardless of the origin, that massive amount of Cerevel data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cerevel Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cerevel Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cerevel Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cerevel Therapeutics alpha.

Cerevel Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Calling All Cerevel Therapeutics Holdings, Inc. Investors Contact Bronstein, Gewirtz Grossman, LLC To Claim Your Losses
05/29/2024
2
AbbVie Stock Price Forecast 200 On The Cards
06/20/2024
3
Why Is Cerevel Therapeutics Holdings, Inc. One of the Best Healthcare Stocks to Buy Under 50
06/27/2024
4
10 clinical trials to watch in the second half of 2024
07/01/2024
5
Entropy Technologies LP Buys Shares of 16,131 Cerevel Therapeutics Holdings, Inc. - MarketBeat
07/18/2024
6
Cerevel Therapeutics gains as investors appear more confident on FTC approval for AbbVie - Seeking Alpha
07/22/2024
7
Cerevel stock ticks higher as AbbVie says it expects deal to close soon
07/25/2024
8
Oil tanker in collision near Pedra Branca did not flee, but had drifted away Malaysian authorities
07/30/2024
9
Disposition of 81065 shares by Burgess Paul D. of Cerevel Therapeutics subject to Rule 16b-3
08/01/2024
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Consideration for investing in Cerevel Stock

If you are still planning to invest in Cerevel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cerevel Therapeutics' history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio